By Justin Petrone
The National Institutes of Health is looking for a partner to commercialize a new tissue microarrayer that its inventor claims could cost one-tenth the price of similar instruments on the market.
Besides the new InnoStamp arrayer, which relies on magnetic stamps to print arrays, the French company plans to launch an infrared version of its InnoScan 710 scanner.
As part of the deal, KTH will also serve as a reference site for Arrayjet, and the two organizations will work together on publications and technology development.
Phadia will use the 2470 in its research efforts to characterize new allergens and to discover biomarker signatures that can be used in the molecular diagnosis of allergies and autoimmune diseases.
CNN reports that researchers have tied a new variant to opioid addiction risk.
Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.
An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.
In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.